Abbott Laboratories - stock earnings
ABT Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
July 18, 2024 BeforeMarket | - / - | 10.2 billion | - / 10.4 billion | 10.5 billion |
ABT Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2024Q1 | 1.2 billion USD | 10.0 billion USD |
2023Q4 | 1.6 billion USD | 10.2 billion USD |
2023Q3 | 1.4 billion USD | 10.1 billion USD |
2023Q2 | 1.4 billion USD | 10.0 billion USD |
2023Q1 | 1.3 billion USD | 9.7 billion USD |
2022Q4 | 1.0 billion USD | 10.1 billion USD |
2022Q3 | 1.4 billion USD | 10.4 billion USD |
2022Q2 | 2.0 billion USD | 11.3 billion USD |
2022Q1 | 2.4 billion USD | 11.9 billion USD |
2021Q4 | 2.0 billion USD | 11.5 billion USD |
2021Q3 | 2.1 billion USD | 10.9 billion USD |
2021Q2 | 1.2 billion USD | 10.2 billion USD |
2021Q1 | 1.8 billion USD | 10.5 billion USD |
2020Q4 | 2.2 billion USD | 10.7 billion USD |
2020Q3 | 1.2 billion USD | 8.9 billion USD |
2020Q2 | 537.0 million USD | 7.3 billion USD |
2020Q1 | 564.0 million USD | 7.7 billion USD |
2019Q4 | 1.0 billion USD | 8.3 billion USD |
2019Q3 | 960.0 million USD | 8.1 billion USD |
2019Q2 | 1.0 billion USD | 8.0 billion USD |
2019Q1 | 672.0 million USD | 7.5 billion USD |
2018Q4 | 654.0 million USD | 7.8 billion USD |
2018Q3 | 563.0 million USD | 7.7 billion USD |
2018Q2 | 733.0 million USD | 7.8 billion USD |
2018Q1 | 418.0 million USD | 7.4 billion USD |
2017Q4 | -828.0 million USD | 7.6 billion USD |
2017Q3 | 603.0 million USD | 6.8 billion USD |
2017Q2 | 283.0 million USD | 6.6 billion USD |
2017Q1 | 419.0 million USD | 6.3 billion USD |
2016Q4 | 798.0 million USD | 5.3 billion USD |
2016Q3 | -329.0 million USD | 5.3 billion USD |
2016Q2 | 615.0 million USD | 5.3 billion USD |
2016Q1 | 316.0 million USD | 4.9 billion USD |
2015Q4 | 767.0 million USD | 5.2 billion USD |
2015Q3 | 580.0 million USD | 5.2 billion USD |
2015Q2 | 784.0 million USD | 5.2 billion USD |
2015Q1 | 2.3 billion USD | 4.9 billion USD |
2014Q4 | 905.0 million USD | 5.4 billion USD |
2014Q3 | 538.0 million USD | 5.1 billion USD |
2014Q2 | 466.0 million USD | 5.6 billion USD |
2014Q1 | 375.0 million USD | 5.2 billion USD |
2013Q4 | 589.0 million USD | 5.7 billion USD |
2013Q3 | 966.0 million USD | 5.4 billion USD |
2013Q2 | 476.0 million USD | 5.4 billion USD |
2013Q1 | 544.0 million USD | 5.4 billion USD |
2012Q4 | 1.1 billion USD | 10.8 billion USD |
2012Q3 | 1.9 billion USD | 9.8 billion USD |
2012Q2 | 1.7 billion USD | 9.8 billion USD |
2012Q1 | 1.2 billion USD | 9.5 billion USD |
2011Q4 | 1.6 billion USD | 10.4 billion USD |
2011Q3 | 303.0 million USD | 9.8 billion USD |
2011Q2 | 1.9 billion USD | 9.6 billion USD |
2011Q1 | 864.0 million USD | 9.0 billion USD |
2010Q4 | 1.4 billion USD | 10.0 billion USD |
2010Q3 | 891.0 million USD | 8.7 billion USD |
2010Q2 | 1.3 billion USD | 8.8 billion USD |
2010Q1 | 1.0 billion USD | 7.7 billion USD |
2009Q4 | 1.5 billion USD | 8.8 billion USD |
2009Q3 | 1.5 billion USD | 7.8 billion USD |
2009Q2 | 1.3 billion USD | 7.5 billion USD |
2009Q1 | 1.4 billion USD | 6.7 billion USD |
2008Q4 | 1.5 billion USD | 8.0 billion USD |
2008Q3 | 1.1 billion USD | 7.5 billion USD |
2008Q2 | 1.3 billion USD | 7.3 billion USD |
2008Q1 | 937.9 million USD | 6.8 billion USD |
2007Q4 | 1.2 billion USD | 7.2 billion USD |
2007Q3 | 717.0 million USD | 6.4 billion USD |
2007Q2 | 988.7 million USD | 6.4 billion USD |
2007Q1 | 697.5 million USD | 5.3 billion USD |
2006Q4 | -476.2 million USD | 6.2 billion USD |
2006Q3 | 715.8 million USD | 5.6 billion USD |
2006Q2 | 612.2 million USD | 5.5 billion USD |
2006Q1 | 864.9 million USD | 5.2 billion USD |
2005Q4 | 976.4 million USD | 6.0 billion USD |
2005Q3 | 680.7 million USD | 5.4 billion USD |
2005Q2 | 877.1 million USD | 5.5 billion USD |
2005Q1 | 837.9 million USD | 5.4 billion USD |
2004Q4 | 974.6 million USD | 5.7 billion USD |
2004Q3 | 804.1 million USD | 4.7 billion USD |
2004Q2 | 634.3 million USD | 4.7 billion USD |
2004Q1 | 822.9 million USD | 5.2 billion USD |
2003Q4 | 944.4 million USD | 5.5 billion USD |
2003Q3 | 761.2 million USD | 4.8 billion USD |
2003Q2 | 246.6 million USD | 4.7 billion USD |
2003Q1 | 801.0 million USD | 4.6 billion USD |
2002Q4 | 627.1 million USD | 4.8 billion USD |
2002Q3 | 720.1 million USD | 4.3 billion USD |
2002Q2 | 592.3 million USD | 4.3 billion USD |
2002Q1 | 854.3 million USD | 4.2 billion USD |
2001Q4 | 613.6 million USD | 4.4 billion USD |
2001Q3 | 631.4 million USD | 4.2 billion USD |
2001Q2 | 529.0 million USD | 4.1 billion USD |
2001Q1 | -223.6 million USD | 3.6 billion USD |
2000Q4 | 753.4 million USD | 3.7 billion USD |
2000Q3 | 654.4 million USD | 3.3 billion USD |
2000Q2 | 685.2 million USD | 3.4 billion USD |
2000Q1 | 693.0 million USD | 3.4 billion USD |
1999Q4 | 670.4 million USD | 3.5 billion USD |
1999Q3 | 466.1 million USD | 3.1 billion USD |
1999Q2 | 642.7 million USD | 3.2 billion USD |
1999Q1 | 666.6 million USD | 3.3 billion USD |
1998Q4 | 626.4 million USD | 3.3 billion USD |
1998Q3 | 531.7 million USD | 3.0 billion USD |
1998Q2 | 585.6 million USD | 3.1 billion USD |
1998Q1 | 589.6 million USD | 3.0 billion USD |
1997Q4 | 566.7 million USD | 3.1 billion USD |
1997Q3 | 471.4 million USD | 2.9 billion USD |
1997Q2 | 521.5 million USD | 2.9 billion USD |
1997Q1 | 534.8 million USD | 3.0 billion USD |
1996Q4 | 510.6 million USD | 3.0 billion USD |
1996Q3 | 420.9 million USD | 2.6 billion USD |
1996Q2 | 470.4 million USD | 2.7 billion USD |
1996Q1 | 480.1 million USD | 2.7 billion USD |
1995Q4 | 465.4 million USD | 2.6 billion USD |
1995Q3 | 382.1 million USD | 2.4 billion USD |
1995Q2 | 424.0 million USD | 2.5 billion USD |
1995Q1 | 417.3 million USD | 2.5 billion USD |
1994Q4 | 422.6 million USD | 2.5 billion USD |
1994Q3 | 351.3 million USD | 2.3 billion USD |
1994Q2 | 376.6 million USD | 2.2 billion USD |
1994Q1 | 366.2 million USD | 2.2 billion USD |
1993Q4 | 391.3 million USD | 2.2 billion USD |
1993Q3 | 316.2 million USD | 2.1 billion USD |
1993Q2 | 346.1 million USD | 2.1 billion USD |
1993Q1 | 345.5 million USD | 2.0 billion USD |
1992Q4 | 349.0 million USD | 2.1 billion USD |
1992Q3 | 278.8 million USD | 2.0 billion USD |
1992Q2 | 317.1 million USD | 1.9 billion USD |
1992Q1 | 294.2 million USD | 1.9 billion USD |
1991Q4 | 314.8 million USD | 1.9 billion USD |
1991Q3 | 251.6 million USD | 1.7 billion USD |
1991Q2 | 268.3 million USD | 1.7 billion USD |
1991Q1 | 254.1 million USD | 1.7 billion USD |
1990Q4 | 279.8 million USD | 1.7 billion USD |
1990Q3 | 220.8 million USD | 1.5 billion USD |
1990Q2 | 240.2 million USD | 1.5 billion USD |
1990Q1 | 225.0 million USD | 1.4 billion USD |
1989Q4 | ? USD | 1.5 billion USD |
1989Q3 | ? USD | 1.3 billion USD |
1989Q2 | ? USD | 1.3 billion USD |
1989Q1 | ? USD | 1.3 billion USD |
1988Q4 | ? USD | 1.3 billion USD |
1988Q3 | ? USD | 1.2 billion USD |
1988Q2 | ? USD | 1.2 billion USD |
1988Q1 | ? USD | 1.2 billion USD |
1987Q4 | ? USD | 1.2 billion USD |
1987Q3 | ? USD | 1.1 billion USD |
1987Q2 | ? USD | 1.1 billion USD |
1987Q1 | ? USD | 1.0 billion USD |
1986Q4 | ? USD | 1.1 billion USD |
1986Q3 | ? USD | 940.9 million USD |
1986Q2 | ? USD | 938.0 million USD |
1986Q1 | ? USD | 865.5 million USD |
1985Q4 | ? USD | 954.4 million USD |
1985Q3 | ? USD | 822.7 million USD |
ABT Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 5.7 billion USD | 40.1 billion USD |
2022 | 6.9 billion USD | 43.7 billion USD |
2021 | 7.1 billion USD | 43.1 billion USD |
2020 | 4.5 billion USD | 34.6 billion USD |
2019 | 3.7 billion USD | 31.9 billion USD |
2018 | 2.4 billion USD | 30.6 billion USD |
2017 | 477.0 million USD | 27.4 billion USD |
2016 | 1.4 billion USD | 20.9 billion USD |
2015 | 4.4 billion USD | 20.4 billion USD |
2014 | 2.3 billion USD | 20.2 billion USD |
2013 | 2.6 billion USD | 21.8 billion USD |
2012 | 6.0 billion USD | 39.9 billion USD |
2011 | 4.7 billion USD | 38.9 billion USD |
2010 | 4.6 billion USD | 35.2 billion USD |
2009 | 5.7 billion USD | 30.8 billion USD |
2008 | 4.9 billion USD | 29.5 billion USD |
2007 | 3.6 billion USD | 25.9 billion USD |
2006 | 1.7 billion USD | 22.5 billion USD |
2005 | 3.4 billion USD | 22.3 billion USD |
2004 | 3.2 billion USD | 19.7 billion USD |
2003 | 2.8 billion USD | 19.7 billion USD |
2002 | 2.8 billion USD | 17.7 billion USD |
2001 | 1.6 billion USD | 16.3 billion USD |
2000 | 2.8 billion USD | 13.7 billion USD |
1999 | 2.4 billion USD | 13.2 billion USD |
1998 | 2.3 billion USD | 12.5 billion USD |
1997 | 2.1 billion USD | 11.9 billion USD |
1996 | 1.9 billion USD | 11.0 billion USD |
1995 | 1.7 billion USD | 10.0 billion USD |
1994 | 1.5 billion USD | 9.2 billion USD |
1993 | 1.4 billion USD | 8.4 billion USD |
1992 | 1.2 billion USD | 7.9 billion USD |
1991 | 1.1 billion USD | 6.9 billion USD |
1990 | 965.8 million USD | 6.2 billion USD |
1989 | 859.8 million USD | 5.4 billion USD |
1988 | 752.0 million USD | 4.9 billion USD |
1987 | 632.6 million USD | 4.4 billion USD |
1986 | 540.5 million USD | 3.8 billion USD |
1985 | 465.3 million USD | 3.4 billion USD |
ABT
List: Contenders
Price: $107.53
Dividend Yield: 2.05%
Forward Dividend Yield: 2.06%
Payout Ratio: 67.48%
Dividend Per Share: 2.20 USD
Earnings Per Share: 3.20 USD
P/E Ratio: 34.97
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 5.1 million
Ebitda: 1.7 billionMarket Capitalization: 185.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 42
DGR3: 10.70%
DGR5: 11.14%
DGR10: 11.53%
DGR20: 5.57%